×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
BCAS1 anticorps (N-Term)
Cet anticorps anti-BCAS1 est un anticorps Lapin Polyclonal détectant BCAS1 dans WB et EIA. Adapté pour Humain.
Aperçu rapide pour BCAS1 anticorps (N-Term) (ABIN950616)
Antigène
Voir toutes BCAS1 Anticorps
BCAS1
(Breast Carcinoma Amplified Sequence 1 (BCAS1))
Reactivité
Toutes les réactivités sur BCAS1 Anticorps
Humain
Hôte
Toutes les hôtes sur BCAS1 Anticorps
Lapin
Clonalité
Toutes les clonalités sur BCAS1 Anticorps
Polyclonal
Conjugué
Tous les conjugués à travers BCAS1 Anticorps
Cet anticorp BCAS1 est non-conjugé
Application
Tous les applications à travers BCAS1 Anticorps.
Western Blotting (WB), Enzyme Immunoassay (EIA)
Détail du produit anti-BCAS1 anticorps
(cache)
Épitope
Tous les épitopes à travers BCAS1 Anticorps.
AA 1-30, N-Term
Specificité
This antibody reacts to BCAS1.
Réactivité croisée (Details)
Species reactivity (tested):Human.
Purification
Affinity chromatography on Protein A
Immunogène
KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BCAS1
Isotype
Ig Fraction
Alternatives
(show)
Information d'application
(cache)
Indications d'application
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Stockage
(cache)
Format
Liquid
Concentration
0.25 mg/mL
Buffer
PBS containing 0.09 % (W/V) sodium azide as preservative
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
4 °C/-20 °C
Stockage commentaire
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Détails sur BCAS1
(cache)
Antigène
BCAS1
(Breast Carcinoma Amplified Sequence 1 (BCAS1))
Autre désignation
BCAS1 / NABC1
Sujet
This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene.Synonyms: AIBC1, Breast carcinoma-amplified sequence 1
ID gène
8537
NCBI Accession
NP_003648
Vus récemment
(cache)
Chat with us , powered by LiveChat